Cargando…
Side-by-side analysis of five clinically tested anti-EpCAM monoclonal antibodies
BACKGROUND: Epithelial cell adhesion molecule (EpCAM) is frequently and highly expressed on human carcinomas. The emerging role of EpCAM as a signalling receptor and activator of the wnt pathway, and its expression on tumor-initiating cells, further add to its attractiveness as target for immunother...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2989956/ https://www.ncbi.nlm.nih.gov/pubmed/21044305 http://dx.doi.org/10.1186/1475-2867-10-44 |